New Data Coming Out of ASCOVideo Categories: Polycythemia Vera
Supported through funding from Incyte
Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.
PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.